DRUG R&D Expenses

Bright Minds Biosciences Inc · R&D Expenses

DRUG logo

DRUG R&D Expenses

Latest reported$33.21M CAD
DRUG TTM R&D Expenses · CAD ($354.71K → $33.21M)
High-resolution chart · PNG

DRUG r&d expenses history

Trailing twelve months (TTM) · CAD. Each value covers four complete reported quarters.

Bright Minds Biosciences Inc R&D Expenses — Trailing twelve months (TTM) (CAD)
Period endingR&D Expenses (CAD)
33,206,637
26,401,869
15,699,795
11,084,509
6,716,359
3,457,756
999,854
1,180,010
1,855,270
3,472,704
4,765,790
4,999,944
6,449,831
7,450,506
9,795,452
12,180,938
11,847,852
12,504,642
9,806,362
6,313,990
4,401,849
1,715,121
676,162
354,712
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.